Summit Securities Group’s CVS Health CVS Stock Holding History

Summit Securities Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-239,000	Closed	-$24.7M	–	1149
2021 Q4	$24.7M	Buy	239,000 +238,726	+87,126%	+$22.1M	1.15%	11
2021 Q3	$2.33M	Sell	274 -81	-23%	-$6.79K	0.18%	133
2021 Q2	$2.96M	Buy	355 +55	+18%	+$4.5K	0.25%	92
2021 Q1	$2.26M	Buy	+300	New	+$21.9K	0.25%	84
2019 Q2	–	Sell	-635	Closed	-$3.42M	–	333
2019 Q1	$3.42M	Hold	635	–	–	0.63%	33
2018 Q4	$4.16M	Buy	+635	New	+$47.4K	0.36%	46

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Summit Securities Group's CVS Position: Q1 2026 in Review

Summit Securities Group reduced its CVS Health (CVS) stake by 95% in Q1 2026, selling an estimated $1.38M and leaving 1,009 shares worth $72.5K. The position accounts for 0.01% of the portfolio, ranked #328.

Summit Securities Group first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $10.1M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Summit Securities Group held 1,009 shares of CVS Health worth $72.5K as of Q1 2026.
Summit Securities Group sold 17,877 CVS Health shares in Q1 2026, an estimated $1.38M.
CVS Health made up 0.01% of Summit Securities Group's portfolio in Q1 2026, its #328 holding.
Summit Securities Group first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
Summit Securities Group's CVS Health position peaked at $10.1M in Q4 2021.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.